Rajkumar Venkatramani, MD
- Texas Medical Center
Director, Clinical Business Operations, Cancer and Hematology Centers
Director, Solid Tumor Programs
Director, Soft Tissue Sarcoma Program
Director, Rare Tumors Program
Associate Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
|Children's Hospital of Los Angeles||fellowship||Pediatric Hematology Oncology||2011|
|University of Illinois College of Medicine at Peoria||residency||Pediatrics||2008|
|University of Illinois College of Medicine at Peoria||internship||Pediatrics||2006|
|Educational Commission for Foreign Medical Graduates||ecfmg||ECFMG||2005|
|Kilpauk Medical College||medical school||Bachelor of Medicine & Surgery||2002|
Dr. Rajkumar Venkatramani, director of clinical business operations for Texas Children's Cancer and Hematology Centers and associate professor of pediatrics at Baylor College of Medicine, is a board-certified pediatric hematologist-oncologist who is internationally recognized for his expertise in the care of children with pediatric solid tumors.
Venkatramani completed his pediatric training at Kings College in London and obtained membership in the Royal College of Pediatrics and Child Health. He completed another pediatric residency at University of Illinois College of Medicine and a fellowship in pediatric hematology oncology at Children’s Hospital Los Angeles. Venkatramani served on the faculty at University of Southern California for three years prior to joining the faculty at Baylor College of Medicine/Texas Children’s Cancer Center in 2014.
At Texas Children’s, Venkatramani has been instrumental in developing a rare tumors program. He has established a national registry for children with rare tumors that will provide important data to physician scientists as they work to find a cure for these often times difficult to treat cancers. As the director of the Rare Tumors Program at Texas Children’s Cancer and Hematology Centers, he is involved in management of children with rare cancers, including: melanoma, thyroid tumors, adrenocortical carcinoma, nasopharyngeal carcinoma, neuroendocrine tumors, pleuropulmonary blastoma and salivary gland tumors.
Venkatramani is also a member of the Children’s Oncology Group (COG) Renal Tumor Committee, where he is actively involved in developing a national clinical trial for children with a type of recurrent or relapsed kidney tumor known as Wilms tumor.
Venkatramani has published more than 60 scientific papers in peer-reviewed journals and has been a recipient of numerous awards, including: The Walter Laug Distinguished Teacher Award for Outstanding Teaching and the Guidance and Inspiration and Outstanding Resident Teacher Award. In 2017, he was appointed to the editorial board of Pediatric Blood and Cancer, the premier publication that focuses on laboratory and clinical investigations for children and adolescents with cancer or blood disorders.
American Board of Pediatrics
American Board of Pediatrics - pediatric hematology/oncology
Councils and Committees
Member, Renal Tumor Committee, Children’s Oncology Group, 2013- present
Member, Rare Tumors Committee, Children’s Oncology Group, 2015-present.
Member, Committee on Medical Education, Texas Pediatric Society, 2015- present
Member, Young Investigator Committee, Children’s Oncology Group, 2017- present
|American Academy of Pediatrics (AAP)||Member|
|American Society of Pediatric Hematology and Oncology (ASPHO)||Member|
|American Thyroid Association||Member|
|Children’s Oncology Group (COG)||Chair, Soft Tissue Sarcoma Committee|
|Texas Pediatric Society||Member|
2021 Star Award for Excellence in Patient Care, Baylor College of Medicine